
Detecting infection complications with nanoscale bacterial buds
Sepsis is an inflammatory overreaction to an infection, viral or bacterial, within the body and is the leading cause of death in hospitals. The reaction causes changes such as an intense fever or lowered blood pressure, which may damage vital organ systems if not promptly treated. Early detection may help save lives, but diagnosing patients with sepsis remains a clinical challenge.
Outer membrane vesicles, or OMVs, are nanoscale buds released from the outer membranes of Gram-negative bacteria in response to stress or other environmental changes. Bacteria use these OMVs to remove unwanted molecules and share helpful biomolecules with each other. OMVs can also trigger an inflammatory response during infection. Detecting these buds may be a quicker and more efficient way to identify Gram-negative bacterial sepsis than current diagnostic methods.

Nico Burgado, an undergraduate student in Lea Michel’s lab at the Rochester Institute of Technology, has been studying OMVs. “Usually, when doctors are trying to diagnose sepsis, the patients are already on antibiotics so when they take blood samples, no bacteria show up,” Burgado said. “We need a way to diagnose sepsis after they give the antibiotics, and a good way to do that is OMV detection.”
Burgado, Michel and their team explored OMVs in relation to E. coli sepsis. “We can detect biomolecules that are specific to the parent bacteria,” Burgado said. “After we isolate the OMVs, these biomarkers can help us determine which bacteria are causing the sepsis.”
In a recent study, the researchers used blood plasma samples collected from hospital patients by clinicians. The Michel team isolated the OMVs from these samples, using centrifugation, syringe filtering and ultracentrifugation. They then used Western blot analysis to detect the presence of E. coli proteins.
“The antigens are specific for E. coli, so if we detect any bands, that should mean that there’s E. coli OMVs in the plasma sample,” Burgado said.
The study showed that OMV detection is a promising method to diagnose Gram-negative sepsis. “The real clinical significance is that it’s a path to diagnosing sepsis, identifying the bacterial cause early on, and treating patients with the right antibiotics before they either have more complications or pass away,” Burgado said.
So far, the team has shown that, for the most part, they can isolate E. coli OMVs from the plasma of sepsis patients and detect E. coli biomarkers in the samples. In future studies, the researchers plan to test the sensitivity and accuracy of their diagnostic method and establish a baseline for detecting OMVs from E. coli and other common sources of bacterial sepsis.

Details
Nico Burgado will present this research from 4:30 to 5:30 p.m. CDT on Monday, March 25, at Discover BMB 2024, the American Society for Biochemistry and Molecular Biology annual meeting in San Antonio. His poster is at Board 273.
Abstract title: Using outer membrane vesicles to diagnosis sepsis in clinical samples
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Lipid biomarkers hold clues to stroke recovery
Scientists at the University of Arizona found that a lipid mediator accumulates with the waves of inflammation associated with stroke and foamy macrophages.

From the JBC archives: Madness, indoles and mercury-based cathartics
A 1907 paper sought to resolve an ongoing question of whether indole, a bacterial molecule in the gut, could cause insanity if overproduced.

From the journals: JBC
Linking modified cysteines to cell migration. Recognizing protein tags for degradation. Disrupting C. difficile toxin production. Read about recent JBC papers on these topics.

Becoming a scientific honey bee
At the World Science Forum, a speaker’s call for scientists to go out and “make honey” felt like the answer to a question Katy Brewer had been considering for a long time.

Mutant RNA exosome protein linked to neurodevelopmental defects
Researchers at Emory University find that a missense mutation impairs RNA exosome assembly and translation and causes neurological disease.

Study sheds light on treatment for rare genetic disorder
Aaron Hoskins’ lab partnered with a drug company to understand how RNA-targeting drugs work on spinal muscular atrophy, a disorder resulting from errors in production of a protein related to muscle movement.